BPB
CVS icon

Badgley, Phelps & Bell’s CVS Health CVS Stock Holding History

Badgley, Phelps & Bell’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$517K Sell
6,198
-157
-2% -$12.9K 0.02% 158
2021
Q1 		$478K Buy
6,355
+132
+2% +$9.62K 0.02% 159
2020
Q4 		$425K Sell
6,223
-600
-9% -$39K 0.02% 162
2020
Q3 		$398K Sell
6,823
-130
-2% -$8.09K 0.02% 157
2020
Q2 		$452K Buy
6,953
+250
+4% +$15.7K 0.02% 147
2020
Q1 		$398K Buy
6,703
+503
+8% +$33.6K 0.03% 142
2019
Q4 		$461K Sell
6,200
-145
-2% -$10.2K 0.02% 149
2019
Q3 		$400K Buy
6,345
+283
+5% +$16.8K 0.02% 148
2019
Q2 		$330K Sell
6,062
-688
-10% -$37K 0.02% 160
2019
Q1 		$364K Sell
6,750
-730
-10% -$45.1K 0.02% 159
2018
Q4 		$490K Buy
7,480
+1,553
+26% +$116K 0.04% 137
2018
Q3 		$467K Sell
5,927
-304
-5% -$21.7K 0.03% 143
2018
Q2 		$401K Sell
6,231
-431
-6% -$28.4K 0.03% 149
2018
Q1 		$414K Sell
6,662
-3,777
-36% -$271K 0.03% 148
2017
Q4 		$757K Sell
10,439
-97,022
-90% -$7.05M 0.05% 127
2017
Q3 		$8.74M Buy
107,461
+1,834
+2% +$145K 0.65% 73
2017
Q2 		$8.5M Buy
105,627
+2,006
+2% +$158K 0.66% 72
2017
Q1 		$8.13M Buy
103,621
+8,966
+9% +$716K 0.66% 75
2016
Q4 		$7.47M Sell
94,655
-16,771
-15% -$1.36M 0.65% 75
2016
Q3 		$9.92M Sell
111,426
-561
-0.5% -$53K 0.87% 36
2016
Q2 		$10.7M Buy
111,987
+2,628
+2% +$262K 0.98% 30
2016
Q1 		$11.3M Buy
109,359
+6,208
+6% +$604K 1.07% 27
2015
Q4 		$10.1M Sell
103,151
-2,583
-2% -$253K 0.99% 32
2015
Q3 		$10.2M Sell
105,734
-637
-0.6% -$67K 1.06% 28
2015
Q2 		$11.2M Buy
106,371
+159
+0.1% +$16.2K 1.09% 29
2015
Q1 		$11M Buy
106,212
+24,312
+30% +$2.46M 1.08% 27
2014
Q4 		$7.89M Sell
81,900
-245
-0.3% -$21.6K 0.77% 65
2014
Q3 		$6.54M Buy
82,145
+3,904
+5% +$308K 0.65% 77
2014
Q2 		$5.9M Buy
78,241
+241
+0.3% +$18.2K 0.59% 81
2014
Q1 		$5.84M Buy
+78,000
New +$5.51M 0.6% 76

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Badgley, Phelps & Bell's CVS Position: Q2 2021 in Review

Badgley, Phelps & Bell reduced its CVS Health (CVS) stake by 2.5% in Q2 2021, selling an estimated $12.9K and leaving 6,198 shares worth $517K. The position accounts for 0.02% of the portfolio, ranked #158.

Badgley, Phelps & Bell first reported a position in CVS in Q1 2014 and has held it in 30 quarters since. The position peaked at $11.3M in Q1 2016. 2,064 funds tracked by Wall St. Rank hold CVS as of Q2 2021.

  • Badgley, Phelps & Bell held 6,198 shares of CVS Health worth $517K as of Q2 2021.
  • Badgley, Phelps & Bell sold 157 CVS Health shares in Q2 2021, an estimated $12.9K.
  • CVS Health made up 0.02% of Badgley, Phelps & Bell's portfolio in Q2 2021, its #158 holding.
  • Badgley, Phelps & Bell first reported a position in CVS Health in Q1 2014 and has held it in 30 quarters since.
  • Badgley, Phelps & Bell's CVS Health position peaked at $11.3M in Q1 2016.
  • 2,064 funds tracked by Wall St. Rank held CVS Health as of Q2 2021.

Based on Badgley, Phelps & Bell's 13F filing for Q2 2021, filed 28 Jul 2021.